BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18578329)

  • 1. [The cardiorenal syndrome and erythropoietin].
    Kes P; Basić-Jukić N; Jurić I; Basić-Kes V
    Acta Med Croatica; 2008; 62 Suppl 1():21-31. PubMed ID: 18578329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors.
    Jie KE; Verhaar MC; Cramer MJ; van der Putten K; Gaillard CA; Doevendans PA; Koomans HA; Joles JA; Braam B
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F932-44. PubMed ID: 16885153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The severe cardiorenal syndrome: 'Guyton revisited'.
    Bongartz LG; Cramer MJ; Doevendans PA; Joles JA; Braam B
    Eur Heart J; 2005 Jan; 26(1):11-7. PubMed ID: 15615794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorenal syndrome.
    Mahapatra HS; Lalmalsawma R; Singh NP; Kumar M; Tiwari SC
    Iran J Kidney Dis; 2009 Apr; 3(2):61-70. PubMed ID: 19395780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
    Silverberg DS; Wexler D; Iaina A
    J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiorenal syndrome, current understanding].
    Ronco F; Ronco C
    Recenti Prog Med; 2009 Apr; 100(4):202-13. PubMed ID: 19554920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome.
    Palazzuoli A; Gallotta M; Iovine F; Nuti R; Silverberg DS
    Int J Clin Pract; 2008 Feb; 62(2):281-6. PubMed ID: 18081797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES study.
    van der Putten K; Jie KE; Emans ME; Verhaar MC; Joles JA; Cramer MJ; Velthuis BK; Meiss L; Kraaijenhagen RJ; Doevendans PA; Braam B; Gaillard CA
    J Nephrol; 2010; 23(4):363-8. PubMed ID: 20383871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardio-renal syndrome and anaemia].
    Jakić M
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():38-45. PubMed ID: 20232550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
    van der Putten K; Braam B; Jie KE; Gaillard CA
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cardiorenal syndrome: an emerging renal disease].
    Fabbian F
    G Ital Nefrol; 2007; 24(2):108. PubMed ID: 17458823
    [No Abstract]   [Full Text] [Related]  

  • 13. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.
    Silverberg DS; Wexler D; Blum M; Tchebiner J; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Zubkov A; Steinbruch S; Iaina A
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S37-45. PubMed ID: 12227725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
    Iaina A; Silverberg DS; Wexler D
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of erythropoietin in a patient with severe congestive heart failure--a case report.
    Carić T; Derek O; Carić D
    Coll Antropol; 2008 Jun; 32(2):641-3. PubMed ID: 18756924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
    Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
    Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fosinopril in the treatment of cardiorenal syndrome in chronic cardiac failure].
    Tereshchenko SN; Zhirov IV
    Ter Arkh; 2009; 81(5):84-8. PubMed ID: 19537594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute decompensated heart failure and the cardiorenal syndrome.
    Liang KV; Williams AW; Greene EL; Redfield MM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation.
    Despas F; Detis N; Dumonteil N; Labrunee M; Bellon B; Franchitto N; Galinier M; Senard JM; Pathak A
    J Hypertens; 2009 Sep; 27(9):1849-54. PubMed ID: 19542895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cardiorenal anemia syndrome and treatment with EPO].
    Karle H; Hansen NE
    Ugeskr Laeger; 2006 Aug; 168(33):2686. PubMed ID: 16953546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.